Unbiased Analysis of Today's Healthcare Issues
Conventional wisdom holds that the prices of pharmaceuticals are higher in the US than in other countries. But is that really the case? And if so, by how much? Which price? The question we need to answer is “which price” do you mean? There is the manufacturer wholesale price (i.e., gross price) which is how…
This weekend I received my second COVID-19 vaccine. While I certainly feel lucky to live in a country with ample vaccine supply, other countries are not so lucky. Let’s take a look at the numbers from the Johns Hopkins University Coronavirus Resource Center. These numbers are updated through May 2, 2021. First, you’ll see that…
Here are a few highlight’s from the March 2021 report on Medicare Payment Policy from the Medicare Payment Advisory Commission (MedPAC). Leading causes of death The leading cause of death are heart disease, cancer, and respiratory disease. Note that these figures are from 2018. MedPAC notes that the 3rd leading cause of death in 2020…
Using data from the National Center for Health Statistics (NCHS) and US Census Bureau, Woolf et al. (2021) find: Between March 1, 2020, and January 2, 2021, the US experienced 2 801 439 deaths, 22.9% more than expected, representing 522 368 excess deaths…The excess death rate was higher among non-Hispanic Black (208.4 deaths per 100 000) than non-Hispanic White…
That is the finding from a study published by Anne Case and Angus Deaton this week in Proceedings from the National Academy of Sciences (PNAS). While COVID-19 has had a clear impact in the last 12 months, in fact figures from the National Center for Health Statistics (NCHS) indicate that American life expectancy peaked in…
On the eve of Martin Luther King Day, let us take a quick look at the impact of COVID-19 by race/ethnicity. CDC reports rates of COVID-19 cases, hospitalizations and deaths. One can see that cases are higher for most minorities (except Asians) relative to Non-Hispanic Whites, but hospitalizations and deaths are much higher for all…
Last year, I published a paper that showed that cancer mortality rates fell by 24% between 2000 and 2016 and further that new cancer drugs accounted for saving 1.3 million lives in the US over that time period. At the end of the paper, we noted that these numbers may be conservative since the use…
That is the conclusion from Woolf et al. (2020) in JAMA this past week. The authors examine rates of COVID-19 mortality in the US between March and October 2020 and compare them with other leading causes of death from March to October 2018. We see that COVID-19 is currently the 3rd leading cause of death…
That is the topic of a commentary I wrote with co-authors Joanna MacEwan and Farzad Ali, titled “Does COVID-19 Threaten the Progress Pharmaceuticals Have Made in Reducing Cancer Mortality Over the Last 20 Years?” An excerpt is below: Cancer mortality rates have fallen significantly over the last 20 years. Between 2000 and 2010, overall age-adjusted…
In a paper by Martin et al. (2020) in Health Affairs, CMS’s Office of the Actuary (OACT) has its annual health care spending estimates for 2019. They found that health care spending in the US was $3.8 trillion in 2019, and increase of 4.7%. The share of the economy dedicated to health care rose slightly,…